ACE2 and chronic obstructive pulmonary disease: This expression was significantly increased in (current or former) smokers with COPD, was not altered in subjects with asthma or asthma–COPD overlap (ACO) and pulmonary gene expression of ACE2 did not differ in ICS-treated and non-ICS-treated obstructive airway disease patients.